Delivery Order SPE2DB22D9239-SPE2DB23FDM93
Award Date
9/25/23
Potential Completion Date
10/17/23
Potential Value
$53K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $78,899 delivery order to DMS Pharmaceutical Group Inc. to supply 3,750 units of the pharmaceutical product ASPARLAS, a 5 ml vial. The firm fixed price order is being fulfilled under the Prime Vendor program, with performance taking place in Park Ridge, Illinois over a period of approximately one month concluding in early October. No subcontractors or set aside designations were indicated. The DLA manages the Department of Defense's global supply chain...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-six thousand two hundred ninety-nine dollars and seventy-nine cents ($26,299.79) by the Defense Logistics Agency to provide 3,750 units of ASPARLAS 3,750 UNIT/5 ML VIAL 5ML injection by November 14, 2023. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $78,899.37 and has an ultimate completion date of April 11, 2023. The contract is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS, a 5 ML vial. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-two thousand five hundred ninety-nine dollars and sixty cents ($52,599.60) by the Defense Logistics Agency to supply 3,750 units of the pharmaceutical product ASPARLAS 3,750 UNIT/5 ML VIAL 5ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a $55,229.58 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the 5 ML vial pharmaceutical product ASPARLAS. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract #SPE2DB22D9367 with DLA, which has a ceiling value of up to $4,999,999 and enables DLA to order a broad...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $59,233.74 contract is for the delivery of 3,750 units of the medication ASPARLAS in 5 ML vials. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3,750 units of the 5 milliliter vial of the pharmaceutical product ASPARLAS. The total potential value of the order is $82,844.34. The contract has a completion date of February 7, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply 3,750 units of ASPARLAS 3,750 UNIT/5 ML VIAL 5ML pharmaceutical products. The delivery order, valued at one hundred five thousand one hundred ninety-nine dollars and twenty cents ($105,199.20), has a completion date of December 27, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. will fulfill the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $110,459.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 3,750 units of the 5 ML ASPARLAS (asparaginase erwinia chrysanthemi) vial to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with...
This federal contract award, valued at $118,467.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 3,750 units of the drug ASPARLAS in 5 mL vials. The contract has an ultimate completion date of April 1, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...